StockData
Alterity Therapeutics Ltd logo

Alterity Therapeutics Ltd (ATHE) stock

ATHENasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as PRNAF
Financials through fiscal 2026, year ended Jun 30, 2026Last filing: 20-F on Aug 28, 2026Score 5/30
$1.70−0.17 (-8.85%)

Close on Nov 18, 2026Market cap $30.81MP/E –Yield –

Alterity Therapeutics shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

For fiscal 2026 it was 210M, up 64.5% from the year before. Over ten years it grew 34.7% a year on average. The highest annual figure on record is 210M in fiscal 2026.

Annual shares outstanding

PeriodPeriod endValueChange
FY2026Jun 30, 2026210M+64.5%
FY2025Jun 30, 2025128M+75.3%
FY2024Jun 30, 202473M+50.3%
FY2023Jun 30, 202349M+0.9%
FY2022Jun 30, 202248M+41.8%
FY2021Jun 30, 202134M+89.6%
FY2020Jun 30, 202018M+45.3%
FY2019Jun 30, 201912M+15.3%
FY2018Jun 30, 201811M0.0%
FY2017Jun 30, 201711M0.0%
FY2016Jun 30, 201611M–

More Alterity Therapeutics figures

See a number that looks wrong?